Stiles Financial Services’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-3,070
Closed -$203K 186
2024
Q3
$203K Sell
3,070
-1,500
-33% -$109K 0.07% 182
2024
Q2
$422K Sell
4,570
-165
-3% -$14.6K 0.16% 113
2024
Q1
$452K Sell
4,735
-55
-1% -$4.62K 0.18% 112
2023
Q4
$365K Sell
4,790
-2,050
-30% -$143K 0.17% 121
2023
Q3
$474K Buy
6,840
+50
+0.7% +$4.02K 0.25% 101
2023
Q2
$641K Buy
6,790
+150
+2% +$13K 0.32% 87
2023
Q1
$549K Buy
6,640
+350
+6% +$27.5K 0.3% 94
2022
Q4
$469K Sell
6,290
-75
-1% -$5.78K 0.27% 100
2022
Q3
$526K Buy
6,365
+525
+9% +$50.5K 0.32% 86
2022
Q2
$555K Sell
5,840
-85
-1% -$8.8K 0.33% 84
2022
Q1
$697K Buy
5,925
+190
+3% +$21.3K 0.35% 80
2021
Q4
$743K Buy
+5,735
New +$669K 0.36% 83

Other funds holding EW

Stiles Financial Services's EW Position: Q4 2024 in Review

Stiles Financial Services sold out of Edwards Lifesciences (EW) in Q4 2024, closing a stake of 3,070 shares — an estimated $203K sold.

Stiles Financial Services first reported a position in EW in Q4 2021 and held it in 12 quarters. The position peaked at $743K in Q4 2021. 1,228 funds tracked by Wall St. Rank hold EW as of Q4 2024.

  • Stiles Financial Services reported no remaining Edwards Lifesciences position as of Q4 2024 after selling out during the quarter.
  • Stiles Financial Services sold 3,070 Edwards Lifesciences shares in Q4 2024, an estimated $203K.
  • Stiles Financial Services first reported a position in Edwards Lifesciences in Q4 2021 and held it in 12 quarters.
  • Stiles Financial Services's Edwards Lifesciences position peaked at $743K in Q4 2021.
  • 1,228 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2024.

Based on Stiles Financial Services's 13F filing for Q4 2024, filed 28 Jan 2025.